Dr. Qing Yu Weng, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-492-3250 |
Babu Singh, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 |
Dr. Ranella Hirsch, MD Dermatology Medicare: Medicare Enrolled Practice Location: 777 Concord Ave Ste 206, Cambridge, MA 02138 Phone: 617-868-8685 |
Dr. Shlomit Halachmi, M.D. PH.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 75 Mount Auburn St, 3w, Cambridge, MA 02138 Phone: 617-495-5182 Fax: 617-384-8144 |
Dr. Kay Shou-mei Kane, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Concord Ave, Suite 4100, Cambridge, MA 02138 Phone: 617-864-8822 Fax: 617-547-5367 |
News Archive
Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites.
A recent tour-de-force study by the US researchers describes a comprehensive approach to completely map mutations to the SARS-CoV-2 receptor-binding domain (RBD) that escape antibody binding – enabling, in turn, rational design of antibody therapeutics and appraisal of the antigenic consequences of viral evolution. The results are currently available in a bioRxiv preprint paper.
A female baby was diagnosed with the deadly Ebola when she was only six days old. According to the health officials in the Democratic Republic of the Congo (DRC), she seemed to have miraculously recovered from the viral infection.
Prof. Smadar Cohen, head of the University's Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, has been awarded the prestigious Rappaport Prize for Excellence in Biomedical Research, an award totaling $100,000. The prize, given by Israel's Rappaport Foundation, is presented annually to a researcher whose research has either significantly advanced or has the potential to significantly advance any medical or biomedical field.
New research appearing online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing heart disease risk factors such as high blood pressure, diabetes, and high cholesterol when compared to the general population.
› Verified 9 days ago